View in EDS

Tumor antigen PRAME is a potential therapeutic target of p53 activation in melanoma cells.

Saved in:
Bibliographic Details
Title: Tumor antigen PRAME is a potential therapeutic target of p53 activation in melanoma cells.
Authors: Lee YK; Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Korea., Heo HH; Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Korea., Kim N; Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Korea., Park UH; Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Korea., Youn H; Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Korea., Moon EY; Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Korea., Kim EJ; Department of Molecular Biology, Dankook University, Cheonan 31116, Korea., Um SJ; Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Korea.
Source: BMB reports [BMB Rep] 2024 Jun; Vol. 57 (6), pp. 299-304.
Publication Type: News
Journal Info: Publisher: Korean Society for Biochemistry and Molecular Biology Country of Publication: Korea (South) NLM ID: 101465334 Publication Model: Print Cited Medium: Internet ISSN: 1976-670X (Electronic) Linking ISSN: 19766696 NLM ISO Abbreviation: BMB Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1976-670X